Cambrex has recorded a 19% fall in net profits to $1.8 million for the second quarter ended June 30, 2008, while sales were up by 5% to $66.2 million. During the quarter, the company experienced lower sales of generic active pharmaceutical ingredients (APIs)...
This information is only available to Chemical Week 24/7 members and subscribers.
Forgot your user ID or password? Click here to have it sent to you.
Not a Chemical Week
24/7 member yet? Here's why you
should be: Searchable online archive
access of the last 2 years
of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers